Pacira BioSciences, Inc. PCRX Business Segments — Total Costs & Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — total costs & expenses?
- Pacira BioSciences, Inc. (PCRX) reported business segments — total costs & expenses of $170.47M in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — total costs & expenses changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — total costs & expenses increased by 2.1% year-over-year, from $166.93M to $170.47M.
- What is the long-term trend for Pacira BioSciences, Inc.'s business segments — total costs & expenses?
- Over 2 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — total costs & expenses has grown at a 8.0% compound annual growth rate (CAGR), from $606.8M to $707.22M.
- What does business segments — total costs & expenses mean?
- This metric represents the aggregate operating and non-operating costs incurred by the reportable segment to support its business activities. It encompasses cost of goods sold, research and development, and selling, general, and administrative expenses. Monitoring this figure helps assess the operational efficiency and cost structure of the segment.